Neuroblastoma
Findings in neuroblastoma reported from Cardiff University, Medical Department
Published in Pain and Central Nervous System Week, September 8th, 2008
"Here, we report a new strategy for suppression of CD59 expression in neuroblastoma using peptides that target regulators of CD59 expression. We identified the neuralrestrictive silencer factor (REST) as a target for modulation of CD59 expression in neuroblastoma. We next designed plasmids that encoded peptides comprising different DNA-binding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
More Articles from Pain and Central Nervous System Week
- American Academy of Neurology
Even without dementia, mental skills decline years before death - American Physical Therapy Association
Physical therapists offer low-cost solution to high-cost expenditures for acute low back pain - American Society for Gastrointestinal Endoscopy
Endoscopic ultrasound highly accurate in evaluating ambiguous radiographic findings of the pancreas - Johns Hopkins Medical Institutions
High cholesterol levels drop naturally in children on high-fat anti-seizure diet, Hopkins study show - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center LA BioMed
Newer cardiac imaging machines effective in detecting coronary artery stenosis - Manning Selvage & Lee
New study shows health benefits of probiotic could extend to the entire body - More from this issue of Pain and Central Nervous System Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
